Related Experiment Video
Updated: Jul 6, 2026
10:00
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Interdisciplinary management recommendations for toxicity associated with interferon-alfa therapy
Axel Hauschild1, Katharina C Kähler, Martin Schäfer
1Department of Dermatology, University Clinic Schleswig-Holstein, Campus Kiel, Germany. ahauschild@dermatology.uni-kiel.de
Summary
Adjuvant interferon-alpha (IFN-alpha) therapy for melanoma is standard care, but causes side effects like flu-like symptoms and gastrointestinal issues. Improved understanding now guides better management and prophylaxis of these common IFN-alpha adverse events.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Adjuvant interferon-alpha (IFN-alpha) therapy has been a standard treatment for melanoma for over a decade.
- Common side effects include flu-like symptoms, gastrointestinal disorders, arthralgias, and neuropsychiatric symptoms.
Purpose of the Study:
- To review the pathomechanisms, incidence, and optimized therapy of IFN-alpha-associated side effects.
- To highlight advancements in managing IFN-alpha adverse events based on new insights.
Main Methods:
- Review of existing literature on IFN-alpha therapy in melanoma.
- Analysis of pathophysiologic mechanisms of common side effects.
- Evaluation of updated clinical management strategies.
Main Results:
- Understanding of IFN-alpha side effect mechanisms has improved.
- Clinical experience and detection of autoantibodies/autoimmunity have refined patient management.
- Optimized therapeutic strategies for managing IFN-alpha side effects have been developed.
Conclusions:
- Management and prophylaxis of IFN-alpha side effects have significantly improved.
- New insights into autoimmunity are crucial for optimizing the clinical pathway.
- This review provides a comprehensive overview of IFN-alpha-associated side effects and their management.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.